• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于上颌窦癌T分期的提议]

[Proposal on T staging of maxillary sinus cancer].

作者信息

Ye M, Tu G Y

机构信息

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1988 Mar;10(2):129-31.

PMID:3208652
Abstract

The TNM staging of maxillary sinus cancer was stipulated by the UICC in 1987 using Ohngren line of demarcation. This report is to discuss the applicability of this staging based on 232 cases of maxillary sinus cancer treated in this hospital. Of 232 cases, the 3-year survival rate for those who received surgery alone was 4/6, for those after radical irradiation, 15.6% (20/128) and for those by combined irradiation and surgery, 43.9% (43/98). The 3-year survival rate for the whole series was 28.9%. To analyze the survival rates of different types of lesion separately, we found that those with involvement of the posterior wall, hence invading the pterygopalatine fossa had poor prognosis with a three year survival rate of 19.5%. And invasion of soft and/or hard palate also gave poor survival. Contrary to the common consensus, invasion of ethmoidal sinuses did not pose a serious prognosis. The feasibility of the Ohngren line in TNM staging was thus questioned. On the basis of our data, a modification of the TNM staging of JJC for maxillary sinus cancer is suggested.

摘要

上颌窦癌的TNM分期由国际抗癌联盟(UICC)于1987年采用昂格伦(Ohngren)分界线予以规定。本报告旨在根据本院治疗的232例上颌窦癌病例探讨该分期的适用性。在这232例病例中,单纯接受手术者的3年生存率为4/6,接受根治性放疗者为15.6%(20/128),接受放疗与手术联合治疗者为43.9%(43/98)。整个系列的3年生存率为28.9%。为分别分析不同类型病变的生存率,我们发现累及后壁从而侵犯翼腭窝者预后较差,3年生存率为19.5%。侵犯软腭和/或硬腭者生存率也较低。与普遍观点相反,筛窦受侵并未造成严重的预后。因此,昂格伦线在TNM分期中的可行性受到质疑。根据我们的数据,建议对上颌窦癌的国际抗癌联盟TNM分期进行修订。

相似文献

1
[Proposal on T staging of maxillary sinus cancer].[关于上颌窦癌T分期的提议]
Zhonghua Zhong Liu Za Zhi. 1988 Mar;10(2):129-31.
2
Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment.鼻窦恶性肿瘤中的淋巴结转移:预后价值与治疗
Arch Otolaryngol Head Neck Surg. 2008 Feb;134(2):170-7. doi: 10.1001/archoto.2007.30.
3
[Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].[151例上颌窦恶性肿瘤患者的预后分析]
Ai Zheng. 2004 Nov;23(11 Suppl):1546-50.
4
An analysis of staging systems for carcinoma of the maxillary sinus.上颌窦癌分期系统分析
Ear Nose Throat J. 1988 Jul;67(7):511-2, 516-20.
5
[Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].[鼻窦原发性非霍奇金淋巴瘤:14例报告]
Ai Zheng. 2007 Aug;26(8):919-22.
6
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
7
A comparative study of the JJC, AJC and UICC T classifications of squamous cell carcinoma of the maxillary sinus.上颌窦鳞状细胞癌JJC、AJC和UICC T分类的比较研究
Nihon Gan Chiryo Gakkai Shi. 1989 Jun 20;24(6):1277-87.
8
Malignant tumors of the nasal cavity and paranasal sinuses.鼻腔和鼻窦恶性肿瘤。
Head Neck. 2002 Sep;24(9):821-9. doi: 10.1002/hed.10143.
9
Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution.上颌窦腺样囊性癌和黏液表皮样癌:来自单一机构的25例患者44年经验报告
J Oral Maxillofac Surg. 2006 Nov;64(11):1592-7. doi: 10.1016/j.joms.2005.11.088.
10
Staging in the treatment of maxillary sinus carcinoma.上颌窦癌治疗中的分期
Chin Med J (Engl). 1986 Sep;99(9):735-40.